Variables related to increased mortality following out-patient pulmonary rehabilitation

Although patients with advanced pulmonary diseases have significant improvement in exercise ability and functional status following comprehensive out-patient pulmonary rehabilitation (OPR), their long-term prognosis once they have reached this stage of their diseases remains poor. To further evaluate predictors of increased mortality in these patients, we related patient characteristics and short-term outcome obtained during OPR assessment of 158 patients to subsequent survival. The time period from OPR to death or collection of survival data was 40.0 +/- 17.1 months. The following variables were tested individually and in stepwise fashion using a proportional hazards model: 1) age; 2) gender; 3) pulmonary diagnosis; 4) prebronchodilator forced expiratory volume in one second (FEV1); 5) arterial oxygen tension (Pa,O2) and arterial carbon dioxide tension (Pa,CO2); 6) body mass index (BMI); 7) pre- and post-OPR 12 min walking distance (12-MW); 8) pre- and post-OPR quality of life, using the Chronic Respiratory Disease Questionnaire (CRDQ); 9) number and type of nonpulmonary diagnoses; and 10) number of medications. Separate survival analyses were performed for all deaths (the total group), respiratory deaths only (nonrespiratory deaths excluded), and nonrespiratory deaths only (respiratory deaths excluded). Forty three patients (27%) died during the study period; and the 3 year survival was 80%. For all three survival analyses, the post-OPR 12-MW was the most significant variable related to prognosis: patients with low timed walking distance had increased mortality both from respiratory and nonrespiratory causes. Other variables related to increased mortality included: elevated Pa,CO2; low pre-OPR 12-MW; reduced Pa,O2; low FEV1; low BMI, increased number of medications, and increased CRDQ dyspnoea. These results indicate that the timed walking distance following out-patient pulmonary rehabilitation is an important predictor of survival in patients with advanced pulmonary disease.

This article has been cited by other articles:

				B. Celli, M. Decramer, S. Kesten, D. Liu, S. Mehra, D. P. Tashkin, and on behalf of the UPLIFT Study Investigators Mortality in the 4-Year Trial of Tiotropium (UPLIFT) in Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 15, 2009; 180(10): 948 - 955. [Abstract] [Full Text] [PDF]

				A. Ferreira, C. Garvey, G. L. Connors, L. Hilling, J. Rigler, S. Farrell, C. Cayou, C. Shariat, and H. R. Collard Pulmonary Rehabilitation in Interstitial Lung Disease: Benefits and Predictors of Response Chest, February 1, 2009; 135(2): 442 - 447. [Abstract] [Full Text] [PDF]

				C. G. Cote, V. M. Pinto-Plata, J. M. Marin, H. Nekach, L. J. Dordelly, and B. R. Celli The modified BODE index: validation with mortality in COPD Eur. Respir. J., November 1, 2008; 32(5): 1269 - 1274. [Abstract] [Full Text] [PDF]

				B. R. Celli Update on the Management of COPD Chest, June 1, 2008; 133(6): 1451 - 1462. [Abstract] [Full Text] [PDF]

				C. G. Cote, C. Casanova, J. M. Marin, M. V. Lopez, V. Pinto-Plata, M. M. de Oca, L. J. Dordelly, H. Nekach, and B. R. Celli Validation and comparison of reference equations for the 6-min walk distance test Eur. Respir. J., March 1, 2008; 31(3): 571 - 578. [Abstract] [Full Text] [PDF]

				M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]

				C. G. Cote, V. Pinto-Plata, K. Kasprzyk, L. J. Dordelly, and B. R. Celli The 6-Min Walk Distance, Peak Oxygen Uptake, and Mortality in COPD Chest, December 1, 2007; 132(6): 1778 - 1785. [Abstract] [Full Text] [PDF]

				R. ZuWallack The Nonpharmacologic Treatment of Chronic Obstructive Pulmonary Disease: Advances in Our Understanding of Pulmonary Rehabilitation Proceedings of the ATS, October 1, 2007; 4(7): 549 - 553. [Abstract] [Full Text] [PDF]

				C. Cote, M. D. Zilberberg, S. H. Mody, L. J. Dordelly, and B. Celli Haemoglobin level and its clinical impact in a cohort of patients with COPD Eur. Respir. J., May 1, 2007; 29(5): 923 - 929. [Abstract] [Full Text] [PDF]

				C. G. Cote, L. J. Dordelly, and B. R. Celli Impact of COPD Exacerbations on Patient-Centered Outcomes Chest, March 1, 2007; 131(3): 696 - 704. [Abstract] [Full Text] [PDF]

				P. Palange, S. A. Ward, K-H. Carlsen, R. Casaburi, C. G. Gallagher, R. Gosselink, D. E. O'Donnell, L. Puente-Maestu, A. M. Schols, S. Singh, et al. Recommendations on the use of exercise testing in clinical practice Eur. Respir. J., January 1, 2007; 29(1): 185 - 209. [Abstract] [Full Text] [PDF]

				A.-I. Raffaele, C. Andrea, P. Claudio, T. Luigi, A. Domenico, S. Aldo, I. Orsola, and R. Franco Drawing Impairment Predicts Mortality in Severe COPD Chest, December 1, 2006; 130(6): 1687 - 1694. [Abstract] [Full Text] [PDF]

				C. Esteban, J.M. Quintana, M. Aburto, J. Moraza, and A. Capelastegui A simple score for assessing stable chronic obstructive pulmonary disease QJM, November 1, 2006; 99(11): 751 - 759. [Abstract] [Full Text] [PDF]

				F. J. Martinez, G. Foster, J. L. Curtis, G. Criner, G. Weinmann, A. Fishman, M. M. DeCamp, J. Benditt, F. Sciurba, B. Make, et al. Predictors of Mortality in Patients with Emphysema and Severe Airflow Obstruction Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1326 - 1334. [Abstract] [Full Text] [PDF]

				P. M. A. Calverley Dynamic Hyperinflation: Is It Worth Measuring? Proceedings of the ATS, May 1, 2006; 3(3): 239 - 244. [Abstract] [Full Text] [PDF]

				J. P. de Torres, E. Cordoba-Lanus, C. Lopez-Aguilar, M. Muros de Fuentes, A. Montejo de Garcini, A. Aguirre-Jaime, B. R. Celli, and C. Casanova C-reactive protein levels and clinically important predictive outcomes in stable COPD patients Eur. Respir. J., May 1, 2006; 27(5): 902 - 907. [Abstract] [Full Text] [PDF]

				P. W. Jones and A. G. N. Agusti Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur. Respir. J., April 1, 2006; 27(4): 822 - 832. [Abstract] [Full Text] [PDF]

				B. R. Celli Chronic Obstructive Pulmonary Disease: From Unjustified Nihilism to Evidence-based Optimism. Proceedings of the ATS, January 1, 2006; 3(1): 58 - 65. [Abstract] [Full Text] [PDF]

				J. P. de Torres, C. Casanova, C. Hernandez, J. Abreu, A. Aguirre-Jaime, and B. R. Celli Gender and COPD in Patients Attending a Pulmonary Clinic Chest, October 1, 2005; 128(4): 2012 - 2016. [Abstract] [Full Text] [PDF]

				A. Casas, J. Vilaro, R. Rabinovich, A. Mayer, J. A. Barbera, R. Rodriguez-Roisin, and J. Roca Encouraged 6-min Walking Test Indicates Maximum Sustainable Exercise in COPD Patients Chest, July 1, 2005; 128(1): 55 - 61. [Abstract] [Full Text] [PDF]

				C. Casanova, C. Cote, J. P. de Torres, A. Aguirre-Jaime, J. M. Marin, V. Pinto-Plata, and B. R. Celli Inspiratory-to-Total Lung Capacity Ratio Predicts Mortality in Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 591 - 597. [Abstract] [Full Text] [PDF]

				T. J Ringbaek and P. Lange Outdoor activity and performance status as predictors of survival in hypoxaemic chronic obstructive pulmonary disease (COPD) Clinical Rehabilitation, March 1, 2005; 19(3): 331 - 338. [Abstract] [PDF]

				J. F. Plankeel, B. McMullen, and N. R. MacIntyre Exercise Outcomes After Pulmonary Rehabilitation Depend on the Initial Mechanism of Exercise Limitation Among Non-Oxygen-Dependent COPD Patients Chest, January 1, 2005; 127(1): 110 - 116. [Abstract] [Full Text] [PDF]

				B. R. Celli, C. G. Cote, J. M. Marin, C. Casanova, M. Montes de Oca, R. A. Mendez, V. Pinto Plata, and H. J. Cabral The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease N. Engl. J. Med., March 4, 2004; 350(10): 1005 - 1012. [Abstract] [Full Text] [PDF]

				V.M. Pinto-Plata, C. Cote, H. Cabral, J. Taylor, and B.R. Celli The 6-min walk distance: change over time and value as a predictor of survival in severe COPD Eur. Respir. J., January 1, 2004; 23(1): 28 - 33. [Abstract] [Full Text] [PDF]

				J.A. Barbera, V.I. Peinado, and S. Santos Pulmonary hypertension in chronic obstructive pulmonary disease Eur. Respir. J., May 1, 2003; 21(5): 892 - 905. [Abstract] [Full Text] [PDF]

				T. Oga, K. Nishimura, M. Tsukino, S. Sato, and T. Hajiro Analysis of the Factors Related to Mortality in Chronic Obstructive Pulmonary Disease: Role of Exercise Capacity and Health Status Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 544 - 549. [Abstract] [Full Text] [PDF]

				T. Oga, K. Nishimura, M. Tsukino, S. Sato, T. Hajiro, A. Ikeda, and M. Mishima Health status measured with the CRQ does not predict mortality in COPD Eur. Respir. J., November 1, 2002; 20(5): 1147 - 1151. [Abstract] [Full Text] [PDF]

				A. Domingo-Salvany, R. Lamarca, M. Ferrer, J. Garcia-Aymerich, J. Alonso, M. Felez, A. Khalaf, R. M. Marrades, E. Monso, J. Serra-Batlles, et al. Health-related Quality of Life and Mortality in Male Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 680 - 685. [Abstract] [Full Text] [PDF]

				P. Almagro, E. Calbo, A. Ochoa de Echaguen, B. Barreiro, S. Quintana, J. L. Heredia, and J. Garau Mortality After Hospitalization for COPD* Chest, May 1, 2002; 121(5): 1441 - 1448. [Abstract] [Full Text] [PDF]

				J. P. de Torres, V. Pinto-Plata, E. Ingenito, P. Bagley, A. Gray, R. Berger, and B. Celli Power of Outcome Measurements to Detect Clinically Significant Changes in Pulmonary Rehabilitation of Patients With COPD* Chest, April 1, 2002; 121(4): 1092 - 1098. [Abstract] [Full Text] [PDF]

				P. Aurora, S.A. Prasad, I.M. Balfour-Lynn, G. Slade, B. Whitehead, and R. Dinwiddie Exercise tolerance in children with cystic fibrosis undergoing lung transplantation assessment Eur. Respir. J., August 1, 2001; 18(2): 293 - 297. [Abstract] [Full Text] [PDF]

				S. Solway, D. Brooks, Y. Lacasse, and S. Thomas A Qualitative Systematic Overview of the Measurement Properties of Functional Walk Tests Used in the Cardiorespiratory Domain Chest, January 1, 2001; 119(1): 256 - 270. [Abstract] [Full Text] [PDF]

				C. Casanova, B. R. Celli, L. Tost, E. Soriano, J. Abreu, V. Velasco, and F. Santolaria Long-term Controlled Trial of Nocturnal Nasal Positive Pressure Ventilation in Patients With Severe COPD Chest, December 1, 2000; 118(6): 1582 - 1590. [Abstract] [Full Text] [PDF]

				P. G Camp, J. Appleton, and W D. Reid Quality of Life After Pulmonary Rehabilitation: Assessing Change Using Quantitative and Qualitative Methods Physical Therapy, October 1, 2000; 80(10): 986 - 995. [Abstract] [Full Text] [PDF]

				J. B. Bowen, J. J. Votto, R. S. Thrall, M. C. Haggerty, R. Stockdale-Woolley, T. Bandyopadhyay, and R. L. ZuWallack Functional Status and Survival Following Pulmonary Rehabilitation Chest, September 1, 2000; 118(3): 697 - 703. [Abstract] [Full Text] [PDF]

				J. A. NEDER, P. W. JONES, L. E. NERY, and B. J. WHIPP Determinants of the Exercise Endurance Capacity in Patients with Chronic Obstructive Pulmonary Disease . The Power-Duration Relationship Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 497 - 504. [Abstract] [Full Text] [PDF]

				B. R. Celli The Importance of Spirometry in COPD and Asthma : Effect on Approach to Management Chest, February 1, 2000; 117 (2009): 15S - 19S. [Abstract] [Full Text] [PDF]

				Inhalation devices and propellants Can. Med. Assoc. J., November 1, 1999; 161(90111): s44 - 50. [Full Text]

				N AMBROSINO Field tests in pulmonary disease Thorax, March 1, 1999; 54(3): 191 - 193. [Full Text]